Encavis AG
ENCVF · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $80 | $119 | $121 | $88 |
| % Growth | -33.2% | -1.8% | 38.3% | – |
| Cost of Goods Sold | $75 | $5 | $9 | $7 |
| Gross Profit | $5 | $114 | $112 | $81 |
| % Margin | 5.8% | 95.6% | 92.3% | 92.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $15 | $13 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $167 | $84 | $54 | $50 |
| Operating Expenses | $11 | $84 | $54 | $50 |
| Operating Income | -$162 | $30 | $58 | $31 |
| % Margin | -203.7% | 25.1% | 48.1% | 35.4% |
| Other Income/Exp. Net | -$34 | -$25 | -$36 | -$38 |
| Pre-Tax Income | -$196 | $5 | $22 | -$7 |
| Tax Expense | -$31 | $14 | $9 | $5 |
| Net Income | -$164 | -$10 | $13 | -$13 |
| % Margin | -205.5% | -8.3% | 10.6% | -14.3% |
| EPS | -1.01 | -0.07 | 0.07 | -0.09 |
| % Growth | -1,342.9% | -200% | 177.8% | – |
| EPS Diluted | -1.01 | -0.068 | 0.073 | -0.086 |
| Weighted Avg Shares Out | 162 | 162 | 161 | 153 |
| Weighted Avg Shares Out Dil | 162 | 162 | 161 | 161 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $5 | $8 | $11 |
| Interest Expense | $35 | $30 | $22 | $29 |
| Depreciation & Amortization | $42 | $41 | $41 | $40 |
| EBITDA | -$118 | $76 | $85 | $62 |
| % Margin | -148.3% | 63.8% | 70% | 70.6% |